Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105440076A details a mild esterification process for tenofovir disoproxil fumarate offering high purity and significant cost reduction in API manufacturing.
Patent CN106366089B reveals a heavy-metal-free route for high-purity isoindoline derivatives ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105669606B details a novel CDI-mediated route for high-optical-purity intermediates. This method ensures stable supply and cost reduction in pharmaceutical intermediates manufacturing without Grignard reagents.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN108840838B reveals stable nickel catalyst for 1,1-diarylethane synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1930112A reveals a Lewis acid-catalyzed route for high-purity quinolone intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN114592027A reveals a novel two-step method for Tauroursodeoxycholic Acid production, offering significant cost reduction in API manufacturing and high-purity outcomes.
Patent CN112409137B reveals inorganic base assisted catalysis for high-purity BINOL. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Patent CN104844554B reveals alkali-free synthesis for high-purity Nebivolol intermediates. Enhances supply chain reliability and reduces purification costs significantly.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Patent CN1438985A details a stereoselective route to gabapentin analogs using chiral enones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel peptide coupling method ensures high purity Nebivolol intermediate with reduced racemization risks for scalable pharmaceutical manufacturing.
Novel DBH inhibitors synthesis via hydrazone cyclization. Cost-effective route for antihypertensive intermediates with high purity specifications.
Patent CN113861066B reveals high-purity synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN102452977A enables liquid phase chlorination for high-purity 2-chloro-5-trichloromethylpyridine. Delivers substantial cost reduction and supply chain reliability for global agrochemical manufacturing.
Patent CN1158244C details a high-purity L-carnitine process from S-chlorosuccinic acid. Discover cost-effective chiral synthesis strategies for pharmaceutical intermediates.
Patent CN116120145A reveals a cost-effective route for 2-chloro-3-fluorotoluene via by-product valorization, offering high-purity agrochemical intermediates.
Patent CN110746334A details a 4-step synthesis of 3-(3-chloropropyl)-4-oxopyrrolidine-1-carboxylate, offering high yield and reduced waste for API manufacturing.
Patent CN112939900A reveals a cost-effective route for Brivaracetam intermediates, eliminating chiral chromatography for scalable pharmaceutical manufacturing.
Patent CN102548956B details a novel Stevens rearrangement process for high-purity DTPA derivatives, offering significant cost reduction and scalability for pharmaceutical manufacturing.